The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma

OBJECTIVES: To investigate the eligibility for maintenance immunotherapy and its impact on the prognosis of advanced urothelial carcinoma treated with first‐line chemotherapy, as the selection biases of the eligible population in the JAVELIN Bladder 100 trial remain unclear. METHODS: We retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozaki, Kai, Hatakeyama, Shingo, Tanaka, Toshikazu, Noro, Daisuke, Tokui, Noriko, Horiguchi, Hirotaka, Okuyama, Yoshiharu, Fujita, Naoki, Okamoto, Teppei, Okamoto, Akiko, Suzuki, Yuichiro, Yamamoto, Hayato, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Ohyama, Chikara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988805/
https://www.ncbi.nlm.nih.gov/pubmed/35474727
http://dx.doi.org/10.1002/bco2.119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988805/
https://www.ncbi.nlm.nih.gov/pubmed/35474727
http://dx.doi.org/10.1002/bco2.119

Ejemplares similares